DE60037876D1 - Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes - Google Patents

Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes

Info

Publication number
DE60037876D1
DE60037876D1 DE60037876T DE60037876T DE60037876D1 DE 60037876 D1 DE60037876 D1 DE 60037876D1 DE 60037876 T DE60037876 T DE 60037876T DE 60037876 T DE60037876 T DE 60037876T DE 60037876 D1 DE60037876 D1 DE 60037876D1
Authority
DE
Germany
Prior art keywords
preparation
endocrine cells
treatment
diabetes
undeveloped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60037876T
Other languages
English (en)
Other versions
DE60037876T2 (de
Inventor
Daniel Pipeleers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beta-Cell NV
Original Assignee
Beta-Cell NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta-Cell NV filed Critical Beta-Cell NV
Publication of DE60037876D1 publication Critical patent/DE60037876D1/de
Application granted granted Critical
Publication of DE60037876T2 publication Critical patent/DE60037876T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60037876T 2000-04-12 2000-04-12 Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes Expired - Lifetime DE60037876T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201326A EP1146117B1 (de) 2000-04-12 2000-04-12 Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes
CA2363971A CA2363971C (en) 2000-04-12 2001-11-26 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus

Publications (2)

Publication Number Publication Date
DE60037876D1 true DE60037876D1 (de) 2008-03-13
DE60037876T2 DE60037876T2 (de) 2009-01-29

Family

ID=32070512

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60037876T Expired - Lifetime DE60037876T2 (de) 2000-04-12 2000-04-12 Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes

Country Status (8)

Country Link
US (1) US6686197B2 (de)
EP (1) EP1146117B1 (de)
AT (1) ATE384781T1 (de)
CA (1) CA2363971C (de)
DE (1) DE60037876T2 (de)
DK (1) DK1146117T3 (de)
ES (1) ES2299417T3 (de)
PT (1) PT1146117E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533480A (ja) * 2001-11-09 2005-11-10 アーテセル・サイエンシズ・インコーポレーテツド 脂肪組織由来間質細胞の膵内分泌分化およびその使用
US20040005301A1 (en) * 2002-02-12 2004-01-08 Goldman Steven A. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
ATE437941T1 (de) 2003-06-20 2009-08-15 Vrije Universiteit Brussel Vub Verfahren zur erzeugung von beta-inselzellen aus exokrinen pankreaszellen
EA201301082A1 (ru) 2011-03-29 2014-01-30 Бета-Селл Нв Способ изготовления инкапсулированных терапевтических продуктов и их применение
US20150099653A1 (en) * 2011-10-28 2015-04-09 Centre National De La Recherche Scientifique Process of diagnostic, prognostic and therapeutic monitoring of solid tumors
US20160228377A1 (en) * 2013-09-19 2016-08-11 Beta-Cell Nv Method for the treatment of diabetes mellitus
EP3049020B1 (de) 2013-09-24 2022-06-15 Giner Life Sciences, Inc. System zur gasbehandlung eines zellimplantats
JP6993003B2 (ja) 2016-11-15 2022-01-13 ガイナー ライフ サイエンシズ，インク． 皮下インプラントとの使用に適した経皮的ガス拡散装置
WO2018204867A1 (en) 2017-05-04 2018-11-08 Giner, Inc. Robust, implantable gas delivery device and methods, systems and devices including same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6110743A (en) * 1995-02-10 2000-08-29 The Regents Of The University Of California Development and use of human pancreatic cell lines

Also Published As

Publication number Publication date
PT1146117E (pt) 2008-05-06
CA2363971C (en) 2011-10-11
ES2299417T3 (es) 2008-06-01
CA2363971A1 (en) 2003-05-26
EP1146117B1 (de) 2008-01-23
DK1146117T3 (da) 2008-05-26
ATE384781T1 (de) 2008-02-15
US6686197B2 (en) 2004-02-03
DE60037876T2 (de) 2009-01-29
EP1146117A1 (de) 2001-10-17
US20020177228A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE212230T1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
ATE195555T1 (de) Verfahren zur herstellung transformierter zellen
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
ATE264689T1 (de) Herstellung von kollagen
DE69715824D1 (de) Verfahren zur herstellung eines implantierbaren verbundwerkstoffs, so hergestellte werkstoffe, und kit zur durchführung des verfahrens
AU3513395A (en) Biological material pre-fixation treatment
ATE330002T1 (de) Verfahren zur herstellung von membranvesikeln
ATE489119T1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
ATE257396T1 (de) Verfahren zur herstellung von stabilem alginatmaterial
DE60037876D1 (de) Verfahren zur Herstellung von entwickelten und unentwickelten Pankreasendokrinezellen, Zellpräparat und Verwendung davon zur Behandlung von Diabetes
DE58907855D1 (de) Verfahren zur herstellung von rinder-pericard-materialien und ihre verwendung.
DE602005002461D1 (de) Einen nanofiltrationsschritt umfassendes verfahren zur aufreinigung von albumin, lösung und zusammensetzung zur therapeutischen anwendung, die dieses enthalten
DE69513186D1 (de) Photokatalysator, methode zur dessen herstellung, und erzeugung von wasserstoff unter verwendung des photokatalysators
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
Kobayashi et al. Epidermal structure created by canine hair follicle keratinocytes enriched with bulge cells in a three‐dimensional skin equivalent model in vitro: implications for regenerative therapy of canine epidermis
FI104093B1 (fi) Menetelmä kasvikumituotteen valmistamiseksi ja kasvikumituotteen käyttö
ATE385252T1 (de) Verfahren zur herstellung von granulatförmigen zusammensetzungen
DE69431092D1 (de) Medizinischer Zement, Verfahren zu seiner Herstellung sowie dessen Verwendung
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
DE3585416D1 (de) Verfahren zur herstellung eines biologischen stoffes.
DE69531496D1 (de) Alginatfasern, verfahren zur herstellung und verwendung
DE50010015D1 (de) Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung
ATE395595T1 (de) Verfahren zur herstellung eines trägers mit immobilisierten viren und verwendung eines derartigen trägers
Akimoto et al. Reconstruction of basement membrane in recombinants of epidermis and dermis of chick embryonic skin in vitro: An electron microscopic study

Legal Events

Date Code Title Description
8364 No opposition during term of opposition